Newsletter | December 19, 2023

12.19.23 -- New Developments In mRNA Vaccine Efficacy Show Promise



New Developments In mRNA Vaccine Efficacy Show Promise

Significant caveats with the current base modification approach for mRNA vaccines still remain and need to be addressed. This article looks at activation of innate immunity, overcoming the limitations of pseudouridine, novel 3-base oligonucleotides, and more.


Secure Tech Transfers Of Biological Products In Sterile Manufacturing

Recognizing what it takes to complete technology transfers effectively and efficiently is crucial to selecting the best partner for your project and product needs.

Spray-Dried Dispersions Enable Local Delivery For Lung Cancer

Learning more about spray drying, as well as two case studies detailing its success, serves as a critical tool in developing innovative and effective lung cancer therapies.

Development Of A Platform Approach To Binding ELISAs

We demonstrate how to reduce the time taken to develop a binding ELISA from over five runs to just two runs for both IgG monoclonal antibodies and Fc fusion proteins.

Digital Transformation In Regulatory: Achieving Excellence Virtually

As the industry looks forward, key decision makers in pharma and biotech companies were surveyed to assess their views on undertaking regulatory processes virtually.

Identify Lead Solid Form Early To Reduce Timelines And Downstream Costs

Devoting early-phase resources for solid form understanding and screening during a drug’s development life cycle is critical, as doing so can help save time and resources on the path to market.

How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Approaching IND: What To Consider In Early Development

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing your early development program and the benefits of housing all activities under one roof.


Participate In BioPlan’s 21st Annual Biopharma Manufacturing Study!

Ensure your voice is included in the bioindustry's most authoritative, comprehensive analysis! Be the first to receive this year's industry benchmarking, and more! For each completed survey BioPlan will either send a $35 Amazon e-gift card or donate up to $3,000 to global health charities. Participate now.


Depixus Announces Strategic Collab With Daiichi Sankyo To Use MAGNA Tech

Viracta Therapeutics Announces ODD Granted By The U.S. FDA To Nana-val

MAPS PBC Submits NDA To The FDA For MDMA-Assisted Therapy For PTSD

Alpha Cognition Announces FDA Acceptance Of NDA For ALPHA-1062

Angle PLC Announces Parsortix Unlocks Opportunities For Drug Discovery

New Insights From Single-Cell Genomics

Charles River Finalizes Agreement With CELLphenomics

DeepMirror Launches Early Access Programme For Its Molecular Drug Design Software

Shuttle Pharma Submits IND App To The U.S. FDA For Ropidoxuridine Phase II Clinical Trial

Nona Biosciences Announces Collaboration With Evive Biotech

Bright Path Labs Is Solving Drug Shortages With Domestic Dev & Mfg Of Cancer Medicines


Is Evaporation Important For Optical Biosensors?

Highly Potent APIs

PBPK Predictive Modeling Services


Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.